A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 Years

Micro-Abstract To improve breast cancer diagnosis, 2 prospective clinical trials were conducted to test (n = 351) and validate (n = 210) Videssa Breast. If used in conjunction with imaging, Videssa Breast could have reduced unnecessary biopsies by up to 67%. These results support the joint use of br...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical breast cancer 2017-11, Vol.17 (7), p.516-525.e6
Hauptverfasser: Lourenco, Ana P, Benson, Kasey L, Henderson, Meredith C, Silver, Michael, Letsios, Elias, Tran, Quynh, Gordon, Kelly J, Borman, Sherri, Corn, Christa, Mulpuri, Rao, Smith, Wendy, Alpers, Josie, Costantini, Carrie, Rohatgi, Nitin, Yang, Rebecca, Haythem, Ali, Biren, Shah, Morris, Michael, Kass, Fred, Reese, David E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Micro-Abstract To improve breast cancer diagnosis, 2 prospective clinical trials were conducted to test (n = 351) and validate (n = 210) Videssa Breast. If used in conjunction with imaging, Videssa Breast could have reduced unnecessary biopsies by up to 67%. These results support the joint use of breast imaging and Videssa Breast to better inform clinical decisions for women under age 50.
ISSN:1526-8209
1938-0666
DOI:10.1016/j.clbc.2017.05.004